SciSparc (SPRC) Payables (2016 - 2025)
SciSparc (SPRC) posted Payables of $783000.0 for Q4 2025, down 46.63% sequentially from $1.5 million in Q2 2025, and down 84.51% YoY from $5.1 million in Q4 2024.
SciSparc (SPRC) Payables (2016 - 2025) Analysis & Trends
SciSparc has reported Payables for 10 years, with the latest figure at $783000.0 in Q4 2025.
- Quarterly Payables fell 84.51% year-over-year to $783000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $783000.0 (down 84.51% YoY) and the FY2025 annual result came in at $783000.0, down 84.51% from the prior year.
- Payables declined to $783000.0 in Q4 2025 per SPRC's latest filing, from $1.5 million in the prior quarter.
- Over five years, Payables peaked at $5.1 million in Q4 2024 and troughed at $354000.0 in Q2 2021.
- A 5-year average of $1.7 million and a median of $1.2 million in 2021 frame the typical range for Payables.
- The sharpest annual moves came in 2024 and 2025: Payables soared 530.3% in 2024, then sank 84.51% in 2025.
- Over 5 years, Payables stood at $1.2 million in 2021, then changed by 0.0% to $1.2 million in 2022, then slumped by 33.11% to $802000.0 in 2023, then jumped by 530.3% to $5.1 million in 2024, then tumbled by 84.51% to $783000.0 in 2025.
- According to Business Quant data, Payables over the past three periods registered $783000.0, $1.5 million, and $5.1 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 108.02 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 428.93 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 35.57 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 622.65 Mn |
| 10 | SciSparc | 836,385.99 | 836,385.99 | - | 783,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 783,000.00 |
| Jun 30, 2025 | 1.47 Mn |
| Dec 31, 2024 | 5.06 Mn |
| Jun 30, 2024 | 3.61 Mn |
| Dec 31, 2023 | 802,000.00 |
| Jun 30, 2023 | 1.25 Mn |
| Dec 31, 2022 | 1.20 Mn |
| Jun 30, 2022 | 874,000.00 |
| Dec 31, 2021 | 1.20 Mn |
| Jun 30, 2021 | 354,000.00 |
| Dec 31, 2020 | 744,000.00 |
| Jun 30, 2020 | 1.17 Mn |
| Dec 31, 2019 | 864,000.00 |
| Jun 30, 2019 | 885,000.00 |
| Dec 31, 2018 | 2.49 Mn |
| Sep 30, 2018 | 1.29 Mn |
| Jun 30, 2018 | 1.08 Mn |
| Mar 31, 2018 | 1.21 Mn |
| Dec 31, 2017 | 1.02 Mn |
| Sep 30, 2017 | 565,000.00 |